Misoprostol for Cervical Ripening: Vaginal or Oral?

Sunday, June 14, 2015

Title: Misoprostol for Cervical Ripening: Vaginal or Oral?

Promenade Ballroom (Long Beach Convention Center)
Suzan Burns, RN , Labor and Delivery, Lutheran Medical Center, Wheat Ridge, CO

Discipline: Childbearing (CB)

Learning Objectives:
  • Learner will describe the study method used to compare the efficacy of oral verses vaginal misoprostol.
  • Learner will verbalize understanding of the results of the data analysis.
  • Learner will identify the application of the study results to patient care.

    • Submission Description:
    The purpose of this double-blind, placebo-controlled RCT was to compare the efficacy of two different routes for administration of misoprostol as a cervical ripening agent for induction of labor at the dose level that is often used clinically. A total of 258 patients were randomized to treatment groups (N = 131 for vaginal misoprostol; N = 127 for oral misoprostol. There was no significance between length of time from administration to Bishop Score > 7 or to delivery for either group.

    See more of: Research Poster Presentations
    << Previous Abstract | Next Abstract >>
    The Association of Women's Health, Obstetric and Neonatal Nurses is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.